Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Biol Sci 2022; 18(11):4466-4467. doi:10.7150/ijbs.75760 This issue Cite

Erratum

MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum

Renjie Yang1,2#, Dong Wang2#, Shen Han2#, Yichao Gu2#, Zhi Li2, Lei Deng2, Aihong Yin2, Yun Gao2, Xiangcheng Li2, Yue Yu2✉, Xuehao Wang1,2✉

1. School of Medicine, Southeast University, Nanjing, China.
2. Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, Jiangsu Province, China.
#These authors contributed equally to this work.

✉ Corresponding authors: Xuehao Wang, School of Medicine, Southeast University, Nanjing, China; Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Scie More

Citation:
Yang R, Wang D, Han S, Gu Y, Li Z, Deng L, Yin A, Gao Y, Li X, Yu Y, Wang X. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. Int J Biol Sci 2022; 18(11):4466-4467. doi:10.7150/ijbs.75760. https://www.ijbs.com/v18p4466.htm
Other styles

File import instruction

Corrected-article in Int J Biol Sci, Volume 18, 43

Citation styles

APA
Yang, R., Wang, D., Han, S., Gu, Y., Li, Z., Deng, L., Yin, A., Gao, Y., Li, X., Yu, Y., Wang, X. (2022). MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. International Journal of Biological Sciences, 18(11), 4466-4467. https://doi.org/10.7150/ijbs.75760.

ACS
Yang, R.; Wang, D.; Han, S.; Gu, Y.; Li, Z.; Deng, L.; Yin, A.; Gao, Y.; Li, X.; Yu, Y.; Wang, X. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. Int. J. Biol. Sci. 2022, 18 (11), 4466-4467. DOI: 10.7150/ijbs.75760.

NLM
Yang R, Wang D, Han S, Gu Y, Li Z, Deng L, Yin A, Gao Y, Li X, Yu Y, Wang X. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. Int J Biol Sci 2022; 18(11):4466-4467. doi:10.7150/ijbs.75760. https://www.ijbs.com/v18p4466.htm

CSE
Yang R, Wang D, Han S, Gu Y, Li Z, Deng L, Yin A, Gao Y, Li X, Yu Y, Wang X. 2022. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs: Erratum. Int J Biol Sci. 18(11):4466-4467.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use